Variant report
Variant | nsv462946 |
---|---|
Chromosome Location | chr6:54403797-54440633 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373182323 | chr6:54404415-54404416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576434714 | chr6:54404417-54404418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145437073 | chr6:54404419-54404420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528154557 | chr6:54404445-54404446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545071811 | chr6:54404474-54404475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564866963 | chr6:54404489-54404490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530837824 | chr6:54404501-54404502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148823841 | chr6:54404528-54404529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371420620 | chr6:54404601-54404602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145319499 | chr6:54404646-54404647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546452770 | chr6:54404736-54404737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377446753 | chr6:54404775-54404776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534797533 | chr6:54404836-54404837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551369110 | chr6:54404853-54404854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186144769 | chr6:54404866-54404867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537370459 | chr6:54404908-54404909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75599623 | chr6:54404909-54404910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571809281 | chr6:54404923-54404924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11965139 | chr6:54404942-54404943 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs536878598 | chr6:54404960-54404961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569968 | chr6:54404993-54404994 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs572935233 | chr6:54405012-54405013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545085920 | chr6:54405047-54405048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79729949 | chr6:54405053-54405054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147634866 | chr6:54405055-54405056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544536411 | chr6:54405056-54405057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142190247 | chr6:54405093-54405094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs243743 | chr6:54405106-54405107 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs191971172 | chr6:54405110-54405111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560047494 | chr6:54405144-54405145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528566607 | chr6:54405165-54405166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551432550 | chr6:54405178-54405179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571322997 | chr6:54405255-54405256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574943936 | chr6:54405275-54405276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113332984 | chr6:54405276-54405277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544151444 | chr6:54405303-54405304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537287806 | chr6:54405310-54405311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567997380 | chr6:54405372-54405373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536536371 | chr6:54405450-54405451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370612364 | chr6:54405483-54405484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563925461 | chr6:54405494-54405495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544174 | chr6:54405504-54405505 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs538763452 | chr6:54405505-54405506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558654699 | chr6:54405523-54405524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575385995 | chr6:54405541-54405542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546260091 | chr6:54405553-54405554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544269934 | chr6:54405561-54405562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560709759 | chr6:54405624-54405625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574684222 | chr6:54405636-54405637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559760802 | chr6:54405647-54405648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54404400-54404800 | Enhancers | Osteobl | bone |
2 | chr6:54404800-54405800 | Weak transcription | Osteobl | bone |
3 | chr6:54405800-54407000 | Enhancers | Osteobl | bone |
4 | chr6:54406000-54406800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr6:54406000-54407400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr6:54406000-54407400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr6:54406400-54406800 | Enhancers | Aorta | Aorta |
8 | chr6:54407200-54407400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:54407400-54411600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:54411600-54411800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:54424000-54426200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |